Home Calendar Movers Compare
S&P 500 655.83 +0.09% Nasdaq 584.98 +0.11% Dow 30 465.06 -0.09% Apple 255.92 +0.11% Nvidia 177.39 +0.93% Tesla 360.59 -5.42%
Market Open | 27 companies reporting this week
Home / Calendar / NVO

NVO

Novo Nordisk
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Novo Nordisk A/S (NVO) is a leading global healthcare company based in Bagsvaerd, Denmark, with a primary focus on diabetes care, obesity management, and hormone replacement therapies. Renowned for its commitment to innovation and research, Novo Nordisk utilizes advanced biotechnology to develop hig...
$36.98
90-day price trend
+1.37% (+$0.50)
Volume 14.70M
52W High $80.56
52W Low $35.12
Market Cap $285.37B
← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data
Consensus EPS
$5.05
Whisper EPS
$5.23
3.5% above consensus
Last Quarter
$6.04
Current Streak
2 Beats
Avg Surprise (4Q)
+2.61%

Next Earnings Report

Reports in 29 days
Report Date May 6, 2026
Whisper Spread +3.47%
Consensus Estimate
$5.05
Official analyst average
Whisper Number
$5.23
What traders expect
Bullish Sentiment: The whisper number is 3.5% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Feb 3, 2026
1-Day: -6.18%
Q3 2025 Nov 5, 2025
1-Day: -4.02%
5-Day: -5.05%
Q2 2025 Aug 6, 2025
1-Day: +7.45%
5-Day: +9.89%
Q1 2025 May 7, 2025
1-Day: -4.00%
5-Day: +0.28%

Revenue & Financial Performance

Revenue Whisper
$91.72B
TWN Proprietary Estimate
Last Quarter Revenue
$78.43B
-8.5% YoY
Gross Margin
80.9%
Net Margin: 34.0%
Quarter Revenue YoY Growth Gross Margin Op Margin Net Income
Q4'25 $78.43B -8.5% 80.9% 40.3% $26.65B
Q3'25 $74.98B +5.1% 76.1% 31.6% $20.01B
Q2'25 $76.86B +12.9% 83.3% 43.5% $26.50B
Q1'25 $78.09B +19.5% 83.5% 49.7% $29.03B
Q4'24 $85.68B +30.1% 84.8% 42.9% $28.23B
Q3'24 $71.31B +21.4% 84.1% 47.4% $27.30B
Q2'24 $68.06B +25.3% 84.9% 38.1% $20.05B
Q1'24 $65.35B +22.5% 84.8% 48.7% $25.41B

Historical Earnings

Last 12 quarters
Quarter Date Consensus Whisper Actual EPS Surprise % Result
Q4 2025 Feb 3, 2026 $5.90 $6.11 $6.04 +2.37% Missed
Q3 2025 Nov 5, 2025 $4.24 $4.41 $4.50 +6.13% Beat
Q2 2025 Aug 6, 2025 $6.00 $6.19 $5.96 -0.67% Missed
Q1 2025 May 7, 2025 $6.07 $6.27 $6.53 +7.58% Beat
Q4 2024 Feb 4, 2025 $6.12 $6.36 $6.34 +3.59% Met
Q3 2024 Nov 6, 2024 $5.92 $6.11 $6.12 +3.38% Met
Q2 2024 Aug 7, 2024 $0.74 $0.78 $0.66 -10.40% Missed
Q1 2024 May 2, 2024 $0.77 $0.80 $0.83 +7.79% Beat
Q4 2023 Jan 31, 2024 $0.66 $0.67 $0.71 +7.58% Beat
Q3 2023 Nov 2, 2023 $0.69 $0.71 $0.73 +5.80% Beat
Q2 2023 Aug 10, 2023 $0.63 $0.64 $0.67 +6.35% Beat
Q1 2023 May 4, 2023 $0.61 $0.63 $0.63 +3.28% Met

Company Information

Symbol
NVO
Company
Novo Nordisk
Market Cap
$285.37B
Sector
HEALTHCARE
Next Earnings
May 6, 2026
include __DIR__ . '/includes/footer.php'; ?>